KRAS and lung carcinoma: Given that homozygous (but not heterozygous) Vps18 KO enhances lung tumor development in K-Ras mice, we further assessed the impact of VPS18 copy number loss and promoter hypermethylation on overall survival in patients with lung cancer harboring K-RAS mutations.